Dapsone: Unapproved Uses or Indications
Overview
Affiliations
Espindola K, Varela E, de Albuquerque R, Figueiredo R, Santos S, Malcher N Int J Mol Sci. 2023; 24(1).
PMID: 36613503 PMC: 9820452. DOI: 10.3390/ijms24010057.
A comprehensive insight into the anti-inflammatory properties of dapsone.
Khalilzadeh M, Shayan M, Jourian S, Rahimi M, Sheibani M, Dehpour A Naunyn Schmiedebergs Arch Pharmacol. 2022; 395(12):1509-1523.
PMID: 36125533 DOI: 10.1007/s00210-022-02297-1.
Ortiz M, Jornada D, Pohlmann A, Guterres S AAPS PharmSciTech. 2015; 16(5):1033-40.
PMID: 25652730 PMC: 4674640. DOI: 10.1208/s12249-015-0283-3.
Dapsone in dermatology and beyond.
Wozel G, Blasum C Arch Dermatol Res. 2013; 306(2):103-24.
PMID: 24310318 PMC: 3927068. DOI: 10.1007/s00403-013-1409-7.
Indomethacin-related leukocytoclastic vasculitis: a case report and review of literature.
Hussain N, Mustafa U, Davis J, Thakkar S, Ali A, Mirrakhimov A Case Rep Dermatol. 2013; 5(1):33-7.
PMID: 23525826 PMC: 3604871. DOI: 10.1159/000348240.